iPSC-hepatocyte organoids as a novel platform to predict AAV gene therapy efficacy

iPSC-hepatocyte organoids as a novel platform to predict AAV gene therapy efficacy

Adeno-associated virus (AAV) vectors are widely used in gene therapy, particularly for liver-targeted treatments. However, predicting human-specific outcomes, such as transduction efficiency and hepatotoxicity, remains challenging. Reliable in vitro models are urgently needed to bridge the gap betwe...

Full description

Saved in:
Bibliographic Details
Main Authors: Estelle Berreur, Giacomo Lazzaroni, Cyrill Roth, Marco Zihlmann, Martina Stirn, Ramona Matheis, Rebecca Xicluna, Ekaterina Breous-Nystrom, Adrian B. Roth
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Molecular Therapy: Methods & Clinical Development
Subjects:
AAV vectors
liver
iPSC
organoids
AAV transduction
AAV serotype
Online Access:http://www.sciencedirect.com/science/article/pii/S2329050125000622
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items